Pelvic endoprosthesis in tumor lesions: experience of N.N. Petrov National Medical Research Center of Oncology
| Autor: | G. I. Gafton, Y. V. Gudz, G. V. Zinovev, M. A. Ebert, I. G. Gafton, M. S. Sinyachkin, A. V. Borodulin, A. B. Gogolev |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Bone and soft tissue sarcomas, tumors of the skin. 14:36-43 |
| ISSN: | 2782-3687 2219-4614 |
| DOI: | 10.17650/2782-3687-2022-14-2-36-43 |
| Popis: | Introduction. Oncological endoprosthesis for tumors of the pelvic bones is rare. It is associated with certain difficulties and is insufficiently investigated.The study objective is to evaluate the results of surgical treatment of patients with tumors of the pelvis performed between 2012 and 2021 at the N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.Materials and methods. The study included 23 patients with primary and secondary tumors of the pelvic bones who underwent limb-saving surgeries with substitution of the postresection defect with an endoprosthesis between 2012 and 2021. Mean follow-up duration was 19 months.Results. The most common postoperative complication was infection of the postoperative wound (n = 8; 35 %). Mechanical complications associated with the installed metallic prosthesis were observed in 4 (17 %) patients. Function al results were evaluated after 6 months using the Musculoskeletal Tumor Society Score (MSTS). Mean score per this scale was 53 % which corresponds to satisfactory outcome.Conclusion. Patients with malignant tumors of the pelvic bones should undergo treatment only in specialized medical facilities. Patients for organ-saving therapy should be carefully selected. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|